79 related articles for article (PubMed ID: 22057046)
1. Characterization of infections of human leukocytes by non-polio enteroviruses.
Hwang JY; Jun EJ; Seo I; Won M; Ahn J; Kim YK; Lee H
Intervirology; 2012; 55(5):333-41. PubMed ID: 22057046
[TBL] [Abstract][Full Text] [Related]
2. An antiviral small-interfering RNA simultaneously effective against the most prevalent enteroviruses causing acute hemorrhagic conjunctivitis.
Jun EJ; Won MA; Ahn J; Ko A; Moon H; Tchah H; Kim YK; Lee H
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):58-63. PubMed ID: 20739472
[TBL] [Abstract][Full Text] [Related]
3. Binding to decay-accelerating factor is not required for infection of human leukocyte cell lines by enterovirus 70.
Haddad A; Nokhbeh MR; Alexander DA; Dawe SJ; Grisé C; Gulzar N; Dimock K
J Virol; 2004 Mar; 78(6):2674-81. PubMed ID: 14990687
[TBL] [Abstract][Full Text] [Related]
4. Coxsackievirus B3-induced production of tumor necrosis factor-alpha, IL-1 beta, and IL-6 in human monocytes.
Henke A; Mohr C; Sprenger H; Graebner C; Stelzner A; Nain M; Gemsa D
J Immunol; 1992 Apr; 148(7):2270-7. PubMed ID: 1312105
[TBL] [Abstract][Full Text] [Related]
5. Cellular tropism of human enterovirus D species serotypes EV-94, EV-70, and EV-68 in vitro: implications for pathogenesis.
Smura T; Ylipaasto P; Klemola P; Kaijalainen S; Kyllönen L; Sordi V; Piemonti L; Roivainen M
J Med Virol; 2010 Nov; 82(11):1940-9. PubMed ID: 20872722
[TBL] [Abstract][Full Text] [Related]
6. Attachment of coxsackievirus B3 variants to various cell lines: mapping of phenotypic differences to capsid protein VP1.
Schmidtke M; Selinka HC; Heim A; Jahn B; Tonew M; Kandolf R; Stelzner A; Zell R
Virology; 2000 Sep; 275(1):77-88. PubMed ID: 11017789
[TBL] [Abstract][Full Text] [Related]
7. Study on the inhibitory effect of antisense phosphorothioate oligodeoxynucleotide on coxsackie virus B replication in vitro.
Qi X; Li X; Liu M
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Sep; 14(3):253-6. PubMed ID: 11498691
[TBL] [Abstract][Full Text] [Related]
8. Functional impairment and killing of human beta cells by enteroviruses: the capacity is shared by a wide range of serotypes, but the extent is a characteristic of individual virus strains.
Roivainen M; Ylipaasto P; Savolainen C; Galama J; Hovi T; Otonkoski T
Diabetologia; 2002 May; 45(5):693-702. PubMed ID: 12107750
[TBL] [Abstract][Full Text] [Related]
9. Influence of pan-caspase inhibitors on coxsackievirus B3-infected CD19+ B lymphocytes.
Jarasch N; Martin U; Zell R; Wutzler P; Henke A
Apoptosis; 2007 Sep; 12(9):1633-43. PubMed ID: 17520192
[TBL] [Abstract][Full Text] [Related]
10. Suppression of proinflammatory cytokines and induction of IL-10 in human monocytes after coxsackievirus B3 infection.
Hofmann P; Schmidtke M; Stelzner A; Gemsa D
J Med Virol; 2001 Aug; 64(4):487-98. PubMed ID: 11468734
[TBL] [Abstract][Full Text] [Related]
11. Enterovirus infection and activation of human umbilical vein endothelial cells.
Saijets S; Ylipaasto P; Vaarala O; Hovi T; Roivainen M
J Med Virol; 2003 Jul; 70(3):430-9. PubMed ID: 12767007
[TBL] [Abstract][Full Text] [Related]
12. All CVB serotypes and clinical isolates induce irreversible cytopathic effects in primary cardiomyocytes.
Ahn J; Joo CH; Seo I; Kim D; Kim YK; Lee H
J Med Virol; 2005 Feb; 75(2):290-4. PubMed ID: 15602738
[TBL] [Abstract][Full Text] [Related]
13. Characterization of coxsackievirus B3 replication in human umbilical vein endothelial cells.
Kühnl A; Rien C; Spengler K; Kryeziu N; Sauerbrei A; Heller R; Henke A
Med Microbiol Immunol; 2014 Aug; 203(4):217-29. PubMed ID: 24615265
[TBL] [Abstract][Full Text] [Related]
14. Persistent infection of human microvascular endothelial cells by coxsackie B viruses induces increased expression of adhesion molecules.
Zanone MM; Favaro E; Conaldi PG; Greening J; Bottelli A; Perin PC; Klein NJ; Peakman M; Camussi G
J Immunol; 2003 Jul; 171(1):438-46. PubMed ID: 12817028
[TBL] [Abstract][Full Text] [Related]
15. Coxsackievirus preferentially replicates and induces cytopathic effects in undifferentiated neural progenitor cells.
Tsueng G; Tabor-Godwin JM; Gopal A; Ruller CM; Deline S; An N; Frausto RF; Milner R; Crocker SJ; Whitton JL; Feuer R
J Virol; 2011 Jun; 85(12):5718-32. PubMed ID: 21471247
[TBL] [Abstract][Full Text] [Related]
16. Antiviral potency of a siRNA targeting a conserved region of coxsackievirus A24.
Jun EJ; Nam YR; Ahn J; Tchah H; Joo CH; Jee Y; Kim YK; Lee H
Biochem Biophys Res Commun; 2008 Nov; 376(2):389-94. PubMed ID: 18793610
[TBL] [Abstract][Full Text] [Related]
17. Antiviral effects of pan-caspase inhibitors on the replication of coxsackievirus B3.
Martin U; Jarasch N; Nestler M; Rassmann A; Munder T; Seitz S; Zell R; Wutzler P; Henke A
Apoptosis; 2007 Mar; 12(3):525-33. PubMed ID: 17211569
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of two coxsackievirus B3 strains: putative influence of virus-receptor interactions on pathogenesis.
Selinka HC; Wolde A; Pasch A; Klingel K; Schnorr JJ; Küpper JH; Lindberg AM; Kandolf R
J Med Virol; 2002 Jun; 67(2):224-33. PubMed ID: 11992583
[TBL] [Abstract][Full Text] [Related]
19. The tyrosine kinase p56lck is essential in coxsackievirus B3-mediated heart disease.
Liu P; Aitken K; Kong YY; Opavsky MA; Martino T; Dawood F; Wen WH; Kozieradzki I; Bachmaier K; Straus D; Mak TW; Penninger JM
Nat Med; 2000 Apr; 6(4):429-34. PubMed ID: 10742150
[TBL] [Abstract][Full Text] [Related]
20. Coxsackievirus B3 replication and persistence in intestinal cells from mice infected orally and in the human CaCo-2 cell line.
Harrath R; Bourlet T; Delézay O; Douche-Aourik F; Omar S; Aouni M; Pozzetto B
J Med Virol; 2004 Oct; 74(2):283-90. PubMed ID: 15332278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
